IntegraGen SA (EPA:ALINT)
France · Delayed Price · Currency is EUR 0.1520
+0.0035 (2.36%)
At close: Jan 30, 2026
IntegraGen Revenue
IntegraGen had revenue of 2.75M EUR in the half year ending June 30, 2025, a decrease of -55.08%. This brings the company's revenue in the last twelve months to 6.61M, down -40.37% year-over-year. In the year 2024, IntegraGen had annual revenue of 8.70M, down -30.99%.
Revenue (ttm)
6.61M
Revenue Growth
-40.37%
P/S Ratio
0.15
Revenue / Employee
165.20K
Employees
40
Market Cap
1.01M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.70M | -3.91M | -30.99% |
| Dec 31, 2023 | 12.60M | -603.74K | -4.57% |
| Dec 31, 2022 | 13.21M | 1.88M | 16.63% |
| Dec 31, 2021 | 11.32M | 2.32M | 25.82% |
| Dec 31, 2020 | 9.00M | 720.00K | 8.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| genOway Société anonyme | 27.16M |
| Poxel | 7.66M |
| Plant Advanced Technologies | 2.22M |
| Oncodesign Precision Medicine Société anonyme | 1.74M |
| GenSight Biologics | 945.00K |
| Aton | 656.93K |
| TME Pharma | 27.00K |
| NFL Biosciences | 164.00 |